5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study

AbstractObjectives: To determine the rate and factors associated with remission (disease activity score (DAS) 28- erythrocyte sedimentation rate (ESR) of <2.6) during a 5-year follow-up after the d...